In addition, Yan et al. investigated whether GSRd could improve non-amyloidogenic pathway by activating estrogen receptor (ER) and found GSRd reduced cognitive and memory impairment in OVX rats, increased sAPPα levels and reduced extracellular Aβ. The gene discussed is ESR1; the disease is memory impairment.